USE OF RECONSTITUTED BASEMENT MEMBRANE EXTRACTS TO STUDY OF THE MECHANISMS OF THE INVASION OF MALIGNANT TUMORS THROUGH BASEMENT MEMBRANES
USE OF RECONSTITUTED BASEMENT MEMBRANE EXTRACTS TO STUDY OF THE MECHANISMS OF THE INVASION OF MALIGNANT TUMORS THROUGH BASEMENT MEMBRANES
批准号:
02807140
负责人:
IWAMOTO Yukihide
金额:
$1.15万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (C)
财政年份:
1990
资助国家:
日本
项目状态:
已结题
起止时间:
1990 至 1992
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Basement membrane are thin extracellular structures surrounding most epithelial tissues, nerves and muscles as well as the lining of most blood and lymph vessels. Tumor invasion of basement membrane is a crucial step in the multistage process which leads to the formation of metastasis. Tumor cells cross basement membranes as they initially invade the lymphatic or vascular beds during dissemination, and they penetrate into their target tissue. It is likely that the invasion of tumor cells through basement membranes involves distinct events, including: a) attachment of tumor cells to laminin in the basement membranes through cell surface receptors; b) secretion of enzymes by tumor cells that cause the degradation of basement membrane barrier, and c) migration of tumor cells into the target tissue. we have used the reconstituted basement membrane molecules formed into barriers in order to investigate the invasiveness of malignant bone and soft tissue tumor cells in vitro. Results obtained from our study were as follows: 1) HT1080 human fibrosarcoma cells attach to the basement membrane via four attachment sites of laminin (YIGSR,PDSGR,RGD,IKVAV) and type IV collagen.2) The binding of tumor cells to laminin in the basement membranes were found to induce the secretion of collagenase IV and motility both of which are crucial factors for the invasion.3) Cyclic AMP analogues and a synthetic peptide, Tyr-Ile-Gly-Ser-Arg (YIGSR), from the B1 chain of laminin were able to suppress the invasiveness of HT1080 human fibrosarcoma cells. These agents were also found to reduce the lung colonization in vivo.4) Not only the cell lines but also the primary cultures of malignant bone and soft tissue tumors showed invasiveness in vitro while non-metastatic cells failed to do so.5) Co-injection of basement membrane extracts facilitated the transplantability of human malignant bone and soft tissue tumors obtained at surgery into nude mice.
期刊论文(130)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Yukihide Iwamoto: "Efficacy of two-route chemotherapy using cisplantin and its antidote,sodium thiosulfate regionally confined malignancy." Acta Orthop.Scand.62. 70-71 (1991)
Yukihide Iwamoto:“使用顺铂及其解毒剂硫代硫酸钠的双路化疗对局部恶性肿瘤的疗效。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
大賀 正義: "CDIによる脊柱側彎症の治療経験-derotation効果について-" 整形外科と災害外科. 40. 158-160 (1991)
Masayoshi Ohga:“用 CDI 治疗脊柱侧凸的经验 - 关于去旋转效果 -” 骨科和灾难外科。 40. 158-160 (1991)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Yukihide Iwamoto: "A new technigue for the reduction and stabitization of spondylolisthesis" Orthopaedics International Edition. 1. 86-91 (1992)
Yukihide Iwamoto:“减少和稳定脊椎滑脱的新技术”骨科国际版。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Yukihide Iwamoto: "YIGSR,a synthefic laminin peptide,inibits the enbacement by cyclophosphamide of experimental lang metastasis of human fibrosacoma cells" Clin.Expl.Metastasis. 10. 183-189 (1992)
Yukihide Iwamoto:“YIGSR,一种合成层粘连蛋白肽,可抑制环磷酰胺对人纤维肉瘤细胞实验性郎转移的包埋”Clin.Expl.Metastasis。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
岩本 幸英: "MRIによる軟部腫瘍の質的診断の可能性:病理組織像との対比" 日整会誌. 66. S838 (1992)
Yukihide Iwamoto:“使用 MRI 定性诊断软组织肿瘤的可能性:与组织病理学图像的比较”日本精工会杂志 66. S838 (1992)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 125 条
Analysis of correlation of angiogeneis and osteoclastogenesis/osteoclastic bone resorption in tumore-induced destruction of bone
-
批准号:19390397
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.65万
-
财政年份:2007
-
负责人:IWAMOTO Yukihide
-
依托单位:
Analysis on oncogenic mechanisms and therapeutic targets in Ewing's sarcoma
-
批准号:14207057
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$32.86万
-
财政年份:2002
-
负责人:IWAMOTO Yukihide
-
依托单位:
Molecular targets for signal transduction involved in the invasion and metastasis of malignant bone and soft tissue tumors.
-
批准号:12557125
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.19万
-
财政年份:2000
-
负责人:IWAMOTO Yukihide
-
依托单位:
EWS-Fli1 fusion gene as a diagnostic and therapeutic molecule for Ewing's sarcoma and PNET
-
批准号:10307034
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$25.08万
-
财政年份:1998
-
负责人:IWAMOTO Yukihide
-
依托单位:
The study of the expression of MMPs and TIMPs in malignant bone and soft tissue tumors, its regulation and therapeutic application
-
批准号:09557124
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$7.04万
-
财政年份:1997
-
负责人:IWAMOTO Yukihide
-
依托单位:
MECHANISMS AND INHITION OF THE INVASION OF MALIGNANT BONE AND SOFT TISSUE TUMORS THROUGH BASEMENT MEMBRANES
-
批准号:06671462
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.15万
-
财政年份:1994
-
负责人:IWAMOTO Yukihide
-
依托单位:
国内基金
海外基金
登录
查看更多内容
TGF-β/lnc-APUE/ZEB1通路促进肝癌转移的机制及生物学意义
-
批准号:32100616
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:李颂扬
-
依托单位:
乳腺癌细胞外泌体miRNA诱导组蛋白修饰表观调控巨噬细胞M2极化的机制探索
-
批准号:31960152
-
项目类别:地区科学基金项目
-
资助金额:39.0万元
-
批准年份:2019
-
负责人:罗达亚
-
依托单位:
内质网蛋白Ei24调控胰腺癌细胞迁移、侵袭的分子机制研究
-
批准号:31970704
-
项目类别:面上项目
-
资助金额:50.0万元
-
批准年份:2019
-
负责人:袁琳
-
依托单位:
泛素连接酶TRIM65通过RhoGAP调控Rho活性促进结直肠癌侵袭转移的分子机制
-
批准号:31970703
-
项目类别:面上项目
-
资助金额:50.0万元
-
批准年份:2019
-
负责人:陈代词
-
依托单位:
HDAC11去ε-氨基长链脂肪酰化机制及功能的研究
-
批准号:31970749
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2019
-
负责人:孙蕾
-
依托单位:
FSTL1诱导结直肠癌相关成纤维细胞活化的分子机制研究
-
批准号:31900569
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2019
-
负责人:谷川莎
-
依托单位:
E3泛素连接酶RNF8在肺癌转移中的作用及机制研究
-
批准号:31900537
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2019
-
负责人:匡静宇
-
依托单位:
靶向纳米颗粒调控HIF-1α通路抑制缺氧三阴性乳腺癌耐药和转移的研究
-
批准号:31900567
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2019
-
负责人:田浩
-
依托单位:
癌蛋白TBC1D3与β-肌动蛋白“对话”促进乳腺癌细胞迁移的分子机制
-
批准号:31801171
-
项目类别:青年科学基金项目
-
资助金额:21.0万元
-
批准年份:2018
-
负责人:王北
-
依托单位:
ARHGEF39通过与STRAP相互作用激活TGF-β/Smad信号通路而促进肝癌侵袭转移的机制研究
-
批准号:81802917
-
项目类别:青年科学基金项目
-
资助金额:21.0万元
-
批准年份:2018
-
负责人:王海啸
-
依托单位: